# A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain

> **NCT07641517** · PHASE2 · RECRUITING · sponsor: **Eli Lilly and Company** · enrollment: 150 (estimated)

## Conditions studied

- Osteoarthritis, Knee
- Chronic Pain

## Interventions

- **DRUG:** LY4065967
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07641517
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-25
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641517, "A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*